サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ガバペンチンの世界市場 - タイプ別、剤形別、用途別、流通チャネル別、世界予測、2023年～2032年
市場調査レポート
商品コード
1382489

ガバペンチンの世界市場 - タイプ別、剤形別、用途別、流通チャネル別、世界予測、2023年～2032年

Gabapentin Market - By Type (Generic, Branded), Dosage Form (Capsule, Tablet, Oral Solution), Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome), Distribution Channel, Global Forecast 2023-2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 157 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ガバペンチンの世界市場 - タイプ別、剤形別、用途別、流通チャネル別、世界予測、2023年～2032年
出版日: 2023年09月14日
発行: Global Market Insights Inc.
ページ情報: 英文 157 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のガバペンチンの市場規模は、てんかん管理におけるガバペンチンの極めて重要な役割に牽引され、2023年から2032年にかけてCAGR 4.9%で成長します。

ガバペンチンは、抗けいれん作用が広く認められており、てんかん治療の主要薬となっています。世界保健機関（WHO）によると、てんかんは全世界で約5,000万人が罹患しており、世界で最も蔓延している神経疾患の1つです。てんかんの有病率が上昇を続ける中、てんかん発作の管理におけるガバペンチンの有効性は、医薬品市場におけるガバペンチンの需要を促進しています。

ブランド品のガバペンチンは、有効性と安全性において定評があるため、2032年までにそこそこの売上シェアを獲得する可能性があります。患者やヘルスケア専門家は、しばしば有名ブランドの信頼性を好み、その品質と一貫した治療成果を信頼しています。ブランドのガバペンチン製剤は広範な調査を経ており、てんかん、神経障害性疼痛、不安障害などの疾患の管理における実績が消費者の信頼を集めています。

レストレスレッグス症候群は、2023-2032年を通じてガバペンチン産業の用途スペクトルを支配する可能性があります。レストレスレッグス症候群の治療にガバペンチンを採用するのは、不快感や不随意運動などの症状を緩和する効果が認められているからです。抗けいれん薬および神経障害性疼痛治療薬として実績のあるガバペンチンのレストレスレッグス症候群への適応外使用は、患者に忍容性の高い選択肢を提供します。睡眠の質を改善し、全体的な快適さを向上させる能力により、ガバペンチンはこの神経疾患の管理においてますます好まれる選択肢となっています。

欧州のガバペンチン市場は、神経疾患の有病率が上昇し、さまざまな適応症で同薬が受け入れられつつあることから、2023年から2032年にかけて大きな成長を記録すると思われます。欧州のヘルスケア制度は効果的な治療を重視しており、てんかんや神経因性疼痛のような疾患の管理におけるガバペンチンの有効性がその需要を後押ししています。さらに、高齢化人口の増加とヘルスケアインフラの進歩が相まって、神経疾患管理の要となるガバペンチンの欧州での市場拡大を後押ししています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 ガバペンチン市場洞察

  • 業界情勢
  • 業界への影響要因
    • 促進要因
      • 神経障害性疼痛の増加
      • ガバペンチンの適応外使用の増加
      • ガバペンチンの適応拡大
      • 疼痛管理の有効な治療オプションとしてのガバペンチンの認知度上昇
    • 業界の潜在的リスク＆課題
      • ガバペンチンに伴う副作用
      • 代替治療の利用可能性
      • ガバペンチンの誤用の増加
  • 成長可能性分析
  • COVID-19影響分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 競合ポジショニング・マトリックス
  • 戦略ダッシュボード

第5章 ガバペンチン市場の推定・予測：タイプ別、2018年～2032年

  • 主要動向：タイプ別
  • ジェネリック
  • ブランド

第6章 ガバペンチン市場の推定・予測：剤形別、2018年～2032年

  • 主要動向：剤形別
  • カプセル
  • 錠剤
  • 内服液

第7章 ガバペンチン市場の推定・予測：用途別、2018年～2032年

  • 主要動向：用途別
  • てんかん
  • 神経障害性疼痛
  • レストレスレッグス症候群
  • その他の用途

第8章 ガバペンチン市場の推定・予測：流通チャネル別、2018年～2032年

  • 主要動向：流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 ガバペンチン市場の推定・予測：地域別、2018年～2032年

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • スイス
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他の中東・アフリカ

第10章 企業プロファイル

  • Pfizer Inc.
  • Glenmark Pharmaceuticals Limited`
  • Sun Pharmaceutical Industries Ltd.
  • Ascend Laboratories, LLC
  • Apotex Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Aurobindo Pharma Ltd.
  • Amneal Pharmaceuticals LLC
  • Cipla Inc.
  • BP Pharmaceuticals Laboratories Company
  • Assertio Holdings, Inc.
  • Arbor Pharmaceuticals, Inc.
  • Zydus Pharmaceuticals, Inc
  • Dr. Reddy's Laboratories Ltd.
図表

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by type (2022)
  • TABLE 3 Market revenue, by dosage form (2022)
  • TABLE 4 Market revenue, by application (2022)
  • TABLE 5 Market revenue, by distribution channel (2022)
  • TABLE 6 Market share, by region (2022)
  • TABLE 7 Global gabapentin market size, by region, 2018 - 2022 (USD Million)
  • TABLE 8 Global gabapentin market size, by region, 2023 - 2032 (USD Million)
  • TABLE 9 Global gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 10 Global gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 11 Global gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 12 Global gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 13 Global gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 14 Global gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 15 Global gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 16 Global gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 17 Industry impact forces
  • TABLE 18 Competitive benchmarking of major market players
  • TABLE 19 Competitive positioning matrix: Classification criteria
  • TABLE 20 Strategic outlook matrix: Classification criteria
  • TABLE 21 Generic market size, by region, 2018 - 2022 (USD Million)
  • TABLE 22 Generic market size, by region, 2023 - 2032 (USD Million)
  • TABLE 23 Branded market size, by region, 2018 - 2022 (USD Million)
  • TABLE 24 Branded market size, by region, 2023 - 2032 (USD Million)
  • TABLE 25 Capsule market size, by region, 2018 - 2022 (USD Million)
  • TABLE 26 Capsule market size, by region, 2023 - 2032 (USD Million)
  • TABLE 27 Tablet market size, by region, 2018 - 2022 (USD Million)
  • TABLE 28 Tablet market size, by region, 2023 - 2032 (USD Million)
  • TABLE 29 Oral solution market size, by region, 2018 - 2022 (USD Million)
  • TABLE 30 Oral solution market size, by region, 2023 - 2032 (USD Million)
  • TABLE 31 Epilepsy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 32 Epilepsy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 33 Neuropathic pain market size, by region, 2018 - 2022 (USD Million)
  • TABLE 34 Neuropathic pain market size, by region, 2023 - 2032 (USD Million)
  • TABLE 35 Restless legs syndrome market size, by region, 2018 - 2022 (USD Million)
  • TABLE 36 Restless legs syndrome market size, by region, 2023 - 2032 (USD Million)
  • TABLE 37 Other applications market size, by region, 2018 - 2022 (USD Million)
  • TABLE 38 Other applications market size, by region, 2023 - 2032 (USD Million)
  • TABLE 39 Hospital pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 40 Hospital pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 41 Retail pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 42 Retail pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 43 Online pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 44 Online pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 45 North America gabapentin market size, by country, 2018 - 2022 (USD Million)
  • TABLE 46 North America gabapentin market size, by country, 2023 - 2032 (USD Million)
  • TABLE 47 North America gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 48 North America gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 49 North America gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 50 North America gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 51 North America gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 52 North America gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 53 North America gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 54 North America gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 55 U.S. gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 56 U.S. gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 57 U.S. gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 58 U.S. gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 59 U.S. gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 60 U.S. gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 61 U.S. gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 62 U.S. gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 63 Canada gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 64 Canada gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 65 Canada gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 66 Canada gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 67 Canada gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 68 Canada gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 69 Canada gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 70 Canada gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 71 Europe gabapentin market size, by country, 2018 - 2022 (USD Million)
  • TABLE 72 Europe gabapentin market size, by country, 2023 - 2032 (USD Million)
  • TABLE 73 Europe gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 74 Europe gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 75 Europe gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 76 Europe gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 77 Europe gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 78 Europe gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 79 Europe gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 80 Europe gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 81 Germany gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 82 Germany gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 83 Germany gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 84 Germany gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 85 Germany gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 86 Germany gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 87 Germany gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 88 Germany gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 89 UK gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 90 UK gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 91 UK gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 92 UK gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 93 UK gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 94 UK gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 95 UK gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 96 UK gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 97 France gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 98 France gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 99 France gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 100 France gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 101 France gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 102 France gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 103 France gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 104 France gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 105 Spain gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 106 Spain gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 107 Spain gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 108 Spain gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 109 Spain gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 110 Spain gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 111 Spain gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 112 Spain gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 113 Italy gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 114 Italy gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 115 Italy gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 116 Italy gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 117 Italy gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 118 Italy gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 119 Italy gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 120 Italy gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 121 Switzerland gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 122 Switzerland gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 123 Switzerland gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 124 Switzerland gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 125 Switzerland gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 126 Switzerland gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 127 Switzerland gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 128 Switzerland gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 129 Rest of Europe gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 130 Rest of Europe gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 131 Rest of Europe gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 132 Rest of Europe gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 133 Rest of Europe gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 134 Rest of Europe gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 135 Rest of Europe gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 136 Rest of Europe gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 137 Asia Pacific gabapentin market size, by country, 2018 - 2022 (USD Million)
  • TABLE 138 Asia Pacific gabapentin market size, by country, 2023 - 2032 (USD Million)
  • TABLE 139 Asia Pacific gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 140 Asia Pacific gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 141 Asia Pacific gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 142 Asia Pacific gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 143 Asia Pacific gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 144 Asia Pacific gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 145 Asia Pacific gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 146 Asia Pacific gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 147 China gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 148 China gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 149 China gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 150 China gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 151 China gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 152 China gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 153 China gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 154 China gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 155 Japan gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 156 Japan gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 157 Japan gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 158 Japan gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 159 Japan gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 160 Japan gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 161 Japan gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 162 Japan gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 163 India gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 164 India gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 165 India gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 166 India gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 167 India gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 168 India gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 169 India gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 170 India gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 171 Australia gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 172 Australia gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 173 Australia gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 174 Australia gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 175 Australia gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 176 Australia gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 177 Australia gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 178 Australia gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 179 South Korea gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 180 South Korea gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 181 South Korea gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 182 South Korea gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 183 South Korea gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 184 South Korea gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 185 South Korea gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 186 South Korea gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 187 Rest of Asia Pacific gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 188 Rest of Asia Pacific gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 189 Rest of Asia Pacific gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 190 Rest of Asia Pacific gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 191 Rest of Asia Pacific gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 192 Rest of Asia Pacific gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 193 Rest of Asia Pacific gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 194 Rest of Asia Pacific gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 195 Latin America gabapentin market size, by country, 2018 - 2022 (USD Million)
  • TABLE 196 Latin America gabapentin market size, by country, 2023 - 2032 (USD Million)
  • TABLE 197 Latin America gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 198 Latin America gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 199 Latin America gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 200 Latin America gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 201 Latin America gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 202 Latin America gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 203 Latin America gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 204 Latin America gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 205 Brazil gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 206 Brazil gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 207 Brazil gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 208 Brazil gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 209 Brazil gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 210 Brazil gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 211 Brazil gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 212 Brazil gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 213 Mexico gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 214 Mexico gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 215 Mexico gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 216 Mexico gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 217 Mexico gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 218 Mexico gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 219 Mexico gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 220 Mexico gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 221 Rest of Latin America gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 222 Rest of Latin America gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 223 Rest of Latin America gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 224 Rest of Latin America gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 225 Rest of Latin America gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 226 Rest of Latin America gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 227 Rest of Latin America gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 228 Rest of Latin America gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 229 Middle East & Africa gabapentin market size, by country, 2018 - 2022 (USD Million)
  • TABLE 230 Middle East & Africa gabapentin market size, by country, 2023 - 2032 (USD Million)
  • TABLE 231 Middle East & Africa gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 232 Middle East & Africa gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 233 Middle East & Africa gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 234 Middle East & Africa gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 235 Middle East & Africa gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 236 Middle East & Africa gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 237 Middle East & Africa gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 238 Middle East & Africa gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 239 South Africa gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 240 South Africa gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 241 South Africa gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 242 South Africa gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 243 South Africa gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 244 South Africa gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 245 South Africa gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 246 South Africa gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 247 Saudi Arabia gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 248 Saudi Arabia gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 249 Saudi Arabia gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 250 Saudi Arabia gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 251 Saudi Arabia gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 252 Saudi Arabia gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 253 Saudi Arabia gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 254 Saudi Arabia gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 255 Rest of Middle East & Africa gabapentin market size, by type, 2018 - 2022 (USD Million)
  • TABLE 256 Rest of Middle East & Africa gabapentin market size, by type, 2023 - 2032 (USD Million)
  • TABLE 257 Rest of Middle East & Africa gabapentin market size, by dosage form, 2018 - 2022 (USD Million)
  • TABLE 258 Rest of Middle East & Africa gabapentin market size, by dosage form, 2023 - 2032 (USD Million)
  • TABLE 259 Rest of Middle East & Africa gabapentin market size, by application, 2018 - 2022 (USD Million)
  • TABLE 260 Rest of Middle East & Africa gabapentin market size, by application, 2023 - 2032 (USD Million)
  • TABLE 261 Rest of Middle East & Africa gabapentin market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 262 Rest of Middle East & Africa gabapentin market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Gabapentin industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by type
  • FIG 8 Growth potential analysis, by dosage form
  • FIG 9 Growth potential analysis, by application
  • FIG 10 Growth potential analysis, by distribution channel
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14
  • FIG 15 Competitive positioning matrix, 2022
  • FIG 16 Strategic dashboard, 2022
目次
Product Code: 6722

Global Gabapentin Market size will grow at 4.9% CAGR from 2023 to 2032, driven by the pivotal role of gabapentin in epilepsy management. Widely recognized for its anticonvulsant properties, gabapentin has become a primary medication for epilepsy treatment. According to the World Health Organization (WHO), epilepsy affects approximately 50 million individuals globally, solidifying its status as one of the most prevalent neurological disorders worldwide. As the prevalence of epilepsy continues to rise, the drug's efficacy in managing seizures fosters increasing utilization, propelling the demand for gabapentin in the pharmaceutical market.

The overall gabapentin market share is categorized based on type, dosage form, application, distribution channel, and region.

Branded gabapentin could capture a modest revenue share by 2032 due to its established reputation for efficacy and safety. Patients and healthcare professionals often prefer the reliability of well-known brands, trusting their quality and consistent therapeutic outcomes. Branded gabapentin formulations have undergone extensive research, garnering trust among consumers for their proven track record in managing conditions such as epilepsy, neuropathic pain, and anxiety disorders.

The restless legs syndrome could dominate the application spectrum of the gabapentin industry throughout 2023-2032. The adoption of gabapentin for treating restless legs syndrome is promoted by its recognized efficacy in alleviating symptoms such as discomfort and involuntary leg movements. As a proven anticonvulsant and neuropathic pain medication, gabapentin's off-label use for restless legs syndrome offers patients a well-tolerated option. Its ability to improve sleep quality and enhance overall comfort makes gabapentin an increasingly favored choice in managing this neurological disorder.

Europe gabapentin market will record significant growth between 2023 and 2032 due to the rising prevalence of neurological disorders and the drug's increasing acceptance for various indications. As European healthcare systems emphasize effective treatments, gabapentin's efficacy in managing conditions like epilepsy and neuropathic pain propels its demand. Additionally, a growing aging population, coupled with advancements in healthcare infrastructure, fuels the market expansion of gabapentin in Europe as it becomes a cornerstone in neurological disorder management.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Secondary
      • 1.6.1.1 Paid sources
      • 1.6.1.2 Public sources
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 Gabapentin industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Region trends
    • 2.1.3 Type trends
    • 2.1.4 Dosage form trends
    • 2.1.5 Application trends
    • 2.1.6 Distribution channel trends

Chapter 3 Gabapentin Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidences of neuropathic pain
      • 3.2.1.2 Increasing off-label use of gabapentin
      • 3.2.1.3 Expanded indications of gabapentin
      • 3.2.1.4 Rising awareness of gabapentin as an effective treatment option for pain management
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Side effects associated with gabapentin
      • 3.2.2.2 Availability of alternative treatments
      • 3.2.2.3 Increasing misuse of gabapentin
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By dosage form
    • 3.3.3 By application
    • 3.3.4 By distribution channel
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive positioning matrix, 2022
  • 4.4 Strategic dashboard, 2022

Chapter 5 Gabapentin Market Estimates and Forecast, By Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by type
  • 5.2 Generic
  • 5.3 Branded

Chapter 6 Gabapentin Market Estimates and Forecast, By Dosage Form, 2018-2032 (USD Million)

  • 6.1 Key trends, by dosage form
  • 6.2 Capsule
  • 6.3 Tablet
  • 6.4 Oral solution

Chapter 7 Gabapentin Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

  • 7.1 Key trends, by application
  • 7.2 Epilepsy
  • 7.3 Neuropathic pain
  • 7.4 Restless legs syndrome
  • 7.5 Other applications

Chapter 8 Gabapentin Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacies
  • 8.3 Retail pharmacies
  • 8.4 Online pharmacies

Chapter 9 Gabapentin Market Estimates and Forecast, By Region, 2018-2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Switzerland
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Pfizer Inc.
  • 10.2 Glenmark Pharmaceuticals Limited`
  • 10.3 Sun Pharmaceutical Industries Ltd.
  • 10.4 Ascend Laboratories, LLC
  • 10.5 Apotex Inc.
  • 10.6 Teva Pharmaceutical Industries Ltd.
  • 10.7 Aurobindo Pharma Ltd.
  • 10.8 Amneal Pharmaceuticals LLC
  • 10.9 Cipla Inc.
  • 10.10 BP Pharmaceuticals Laboratories Company
  • 10.11 Assertio Holdings, Inc.
  • 10.12 Arbor Pharmaceuticals, Inc.
  • 10.13 Zydus Pharmaceuticals, Inc
  • 10.14 Dr. Reddy's Laboratories Ltd.